Should you build or buy Commercial Underwriting Submission Triage and Intake AI?
Commercial underwriting submission triage and intake AI software automates the intake of commercial insurance submissions — extracting structured risk data from PDFs, emails, and ACORD forms, enriching it with third-party data, and routing submissions to underwriters based on appetite logic and risk class. It replaces manual data entry and first-pass review in commercial lines underwriting operations.
Copy reviewed 2026-09-27 · Research revision 2026-09-20
Sources: actuary.info; beazley.com
License the intake and document-intelligence layer, then own the decisioning that sits on top of it. Broker email bundles still run 30%+ exception rates and schedules and SOVs 25%+ even with strong models, so what a vendor is actually selling you is format coverage across every broker in your book plus the connectors into policy admin and rating — commodity plumbing you would spend a year reproducing. The appetite ontology, referral thresholds and portfolio context are the opposite case: they encode which risks you want and how fast you can say yes, and they belong in-house from the first day. Keep field-level confidence and provenance, keep the model plane swappable, and treat the language model as a probabilistic extractor rather than an underwriting authority.
Build it, buy it, or bridge?
When building makes sense
GenAI has genuinely shifted this calculation since 2024, and building is now a serious option for carriers with real engineering capacity behind it. AIG is the proof: its AI-assisted intake system, built with Anthropic and Palantir, now processes the full private and nonprofit submission flow inside Financial Lines and has crossed 370,000 E&S submissions toward a 500,000 target by 2030, without adding underwriters. That is a very large carrier with a dedicated AI operation and enterprise infrastructure partners behind it, not a template every carrier can repeat quickly. The stronger and more broadly applicable case for building is on the decisioning side. Appetite logic (which submissions to prioritize, which risk classes to route to which underwriters, which brokers get fast-track handling) is proprietary strategy that carriers don't want embedded in a vendor platform they don't fully control. Beazley, Convex, and a major Canadian carrier all licensed their document-intake and extraction layer rather than building it, and configured their own appetite rules on top: license the extraction, own the decisioning is the pattern the evidence actually supports. If your triage logic is a competitive differentiator, owning that logic in code you control matters even when the intake layer itself comes from a vendor.
When buying makes sense
Buying holds when time-to-value matters more than owning the extraction pipeline outright, and the evidence says that's most carriers. Beazley, Convex, Zurich across its multi-country rollout, and a major Canadian carrier all licensed the document-intake layer rather than building it, then configured their own appetite rules on top of a vendor's extraction. Platforms like Convr and Planck provide that extraction layer plus third-party risk enrichment such as industry classifications, business descriptions, and public records, which gives underwriters context they can't get from the submission document alone. That enrichment data is harder to replicate than extraction itself. Building an intake pipeline without it means your underwriters are still doing manual research on unfamiliar risks. AIG is the exception that proves the rule: it built its own intake system, but only with Anthropic and Palantir as infrastructure partners and a scale, 500,000 submissions targeted by 2030, that makes the build economics work in a way they don't for most carriers.
The desk read
GenAI has genuinely shifted this category's build-vs-buy calculation since 2024. The document extraction layer, parsing submissions, pulling structured risk data from PDFs and emails, is now something carrier teams can build with LLM APIs at a fraction of what it cost two years ago. Vendors like Convr and Planck provide extraction plus risk enrichment data, which is harder to replicate. But the appetite logic, which submissions to prioritize, which risk classes to decline, which brokers to route to which underwriters, is proprietary strategy that carriers don't want vendor platforms holding.
AIG has deployed a production AI intake layer on that basis, built with Anthropic and Palantir at a scale most carriers can't match. Elsewhere the vendor case holds: Beazley, Convex, Zurich's multi-country rollout, and a major Canadian carrier all licensed the intake layer and built their appetite rules on top of it. The vendor case holds when you want faster time-to-value, when the Planck data enrichment layer adds signal you can't replicate internally, or when your submission volume doesn't justify AIG-scale investment. Prices in this category are under pressure as the core extraction problem becomes more DIY-able.
Vendors in Commercial Underwriting Submission Triage and Intake AI
Each file covers what the product is, its funding history, and when the index last verified it alive.
Frequently asked
What is Commercial Underwriting Submission Triage and Intake AI?
The hard part was never reading a PDF; it's deciding which of hundreds of daily submissions deserves an underwriter's attention first. That routing decision, built on appetite rules and risk class, is what separates triage software from plain document extraction.
When does building Commercial Underwriting Submission Triage and Intake AI make sense?
Building is defensible for carriers with capable ML engineering teams: the appetite decisioning logic is proprietary strategy best kept in code you control, and the extraction layer itself is tractable with current models. AIG is the clearest production case, built with Anthropic and Palantir at real scale; most other carriers with production intake systems licensed that layer instead.
When does buying Commercial Underwriting Submission Triage and Intake AI make sense?
Buying makes sense when you need faster time-to-value, lack ML engineering capacity, or when the vendor's third-party risk enrichment data (Planck-style) adds signal you can't replicate internally — the data layer is often the durable value in these platforms.
What are the main Commercial Underwriting Submission Triage and Intake AI vendors?
Representative vendors include Convr, Federato (RiskOps), SortSpoke, IntellectAI, Planck. B4 Pro includes the category score and the full vendor list.
How has GenAI changed the build-vs-buy calculus for submission triage?
GenAI has materially lowered the cost of the document extraction layer — what required $100K–500K in vendor licensing two years ago is now approximatable with LLM APIs and structured extraction pipelines. Vendor pricing is under downward pressure, and the risk enrichment data layer is becoming the clearer differentiator in vendor selection.